著者

Tadao Aikawa Jiro Ogino Nozomi Aikawa Noriko Oyama-Manabe

出版者

The Japanese Society of Internal Medicine

雑誌

Internal Medicine (ISSN:09182918)

巻号頁・発行日

vol.61, no.10, pp.1623-1624, 2022-05-15 (Released:2022-05-15)

被引用文献数

2

著者

Kazuhiro Koyanagawa Yuta Kobayashi Tadao Aikawa Atsuhito Takeda Hideaki Shiraishi Satonori Tsuneta Noriko Oyama-Manabe Hiroyuki Iwano Toshiyuki Nagai Toshihisa Anzai

出版者

Japanese Society for Magnetic Resonance in Medicine

雑誌

Magnetic Resonance in Medical Sciences (ISSN:13473182)

巻号頁・発行日

pp.bc.2020-0069, (Released:2020-09-07)

参考文献数

18

被引用文献数

1

---

To assess myocardial fibrosis associated with muscular dystrophy, T1-mapping and extracellular volume fraction (ECV) quantification was prospectively performed using cardiovascular MR (CMR) imaging in 6 male patients with muscular dystrophy and 5 female putative carriers of Duchenne or Becker muscular dystrophy. Five patients and all putative carriers had an elevated ECV (>29.5% for men and >35.2% for women), suggesting that ECV has a potential to detect diffuse fibrotic changes in patients and putative carriers of muscular dystrophy.

著者

Tadao Aikawa Jiro Ogino Noriko Oyama-Manabe Naohiro Funayama

出版者

The Japanese Society of Internal Medicine

雑誌

Internal Medicine (ISSN:09182918)

巻号頁・発行日

pp.0137-22, (Released:2022-06-28)

参考文献数

2

被引用文献数

1

著者

Osamu Manabe Masanao Naya Keiichiro Yoshinaga Noriko Oyama-Manabe Hiroshi Ohira Tadao Aikawa Nagara Tamaki

出版者

Japanese Society of Nuclear Cardiology

雑誌

Annals of Nuclear Cardiology (ISSN:21893926)

巻号頁・発行日

vol.3, no.1, pp.205-209, 2017 (Released:2017-10-31)

参考文献数

25

被引用文献数

1

---

Cardiac positron emission tomography (PET) has evolved over the several decades since its introduction. In current clinical practice and research, cardiac PET imaging is accepted as a valuable noninvasive modality for assessing various cardiac diseases such as coronary artery disease (CAD), cardiac tumors, and inflammatory diseases including cardiac sarcoidosis (CS). PET enables the imaging and evaluation of the cardiovascular system by myocardial perfusion with 82Rb, 13N-NH3 and 15O-H2O, and those of metabolism and inflammation using 18F-fluorodeoxyglucose (18F-FDG). PET has demonstrated superior diagnostic accuracy for the detection of CAD and also has well-established prognostic value. The combination of qualitative and absolute quantifications of myocardial blood flow enhances the diagnostic accuracy for multiple-vessel disease and provides incremental functional and prognostic information. In this review, we focus on the current and future roles of cardiac PET imaging, on the basis of our own experience.